Peptides
Vilon
Shop Vilon on KimeraChems · code GUIDE (10% off)Definition
Vilon, also referenced in research literature as the KE dipeptide (Lys-Glu), is one of the shortest bioactive compounds studied in peptide biology, consisting of just two amino acids. Despite its minimal size, research demonstrates measurable effects across a broad range of cellular pathways in controlled laboratory environments. Vilon operates primarily at the gene regulation level, penetrating cell nuclei and binding directly to double-stranded DNA to influence the expression of hundreds of genes simultaneously. Its research profile spans immune system modulation, cellular aging and telomere biology, cardiovascular gene regulation, and tissue repair, positioning it as one of the more broadly studied bioregulator peptides in the longevity and geroprotection literature.
Mechanism of Action
- Direct DNA binding at GCGC sequences with laboratory studies demonstrating that Vilon binds double-stranded DNA in cell nuclei targeting GCGC motifs found in the promoter regions of 642 genes, allowing simultaneous multi-gene regulation from a single interaction
- Histone protein interaction and chromatin remodeling with the peptide influencing histone binding in a way that may alter chromatin structure, affecting gene accessibility and transcription factor binding across multiple regulatory loci
- NF-kB pathway modulation via CHUK gene targeting specifically regulating a gene encoding components of the NF-kB signaling pathway, one of the master regulators of inflammation and immune cell activation
- T-cell differentiation and immune marker upregulation stimulating T-cell maturation and promoting CD4 and CD5 expression in thymic cell cultures, with research showing up to a 6-fold reduction in inflammatory cytokine synthesis in stimulated immune cell preparations
- Telomere length normalization and chromatin remodeling in aging cells increasing euchromatin proportion while decreasing heterochromatin in aging cell models, with downstream effects on cellular senescence and genomic stability
- Aging-related gene regulation including IGF1, FOXO1, TERT, and NFkB in mesenchymal stem cell cultures, with reduced apoptosis markers observed in aging cell preparations treated with the peptide
- ACE2, AKT1, and AKT2 gene expression influence in cardiovascular research models, with implications for angiotensin signaling, cellular survival pathways, and angiogenesis regulation
- Heat shock protein and stress response modulation affecting cellular stress tolerance mechanisms alongside MMP-9 regulation and Ki-67 upregulation in fibroblast cultures, suggesting applications in tissue repair research
Areas of Investigation
- Broad multi-gene regulatory activity with a single dipeptide capable of influencing the promoter regions of hundreds of genes simultaneously, offering a uniquely efficient mechanism compared to single-target compounds
- Immune system modulation and anti-inflammatory activity through NF-kB pathway regulation and direct suppression of pro-inflammatory cytokine synthesis in immune cell models
- Cellular aging and geroprotective applications with telomere normalization, euchromatin promotion, and regulation of core longevity genes like TERT and FOXO1 making Vilon one of the more mechanistically grounded peptides in the anti-aging research space
- Cardiovascular gene regulation influencing ACE2 expression and AKT-mediated survival and angiogenesis pathways in research models relevant to vascular health
- Tissue repair and cellular renewal support through MMP-9 regulation and Ki-67 upregulation in fibroblast preparations, suggesting relevance in connective tissue and wound healing research contexts
- Reduced apoptosis in aging cell models with treated preparations showing lower programmed cell death markers, contributing to the overall cellular longevity profile of the compound
Safety Profile
- Favorable tolerability profile consistent with short bioregulator peptides derived from naturally occurring amino acid sequences, generally well tolerated in research populations
- Limited long-term human clinical data with most available research conducted in cell culture and animal models, warranting a measured approach to dosing until more comprehensive human safety data is available
- Injection site reactions possible with subcutaneous administration, manageable with proper technique and site rotation
Disclaimer
For educational purposes only. Not for human consumption.